Metagenomi Common Stock Stock Performance
| MGX Stock | 1.63 0.03 1.81% |
The company secures a Beta (Market Risk) of 1.92, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Metagenomi Common will likely underperform. At this point, Metagenomi Common Stock has a negative expected return of -0.55%. Please make sure to verify Metagenomi Common's total risk alpha and day median price , to decide if Metagenomi Common Stock performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Metagenomi Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Disposition of 1602 shares by Irish Jian of Metagenomi, Common at 1.7719 subject to Rule 16b-3 | 12/05/2025 |
2 | Disposition of 1576 shares by Wapnick Pamela of Metagenomi, Common at 1.7719 subject to Rule 16b-3 | 12/12/2025 |
3 | Brokerages Set Metagenomi, Inc. Price Target at 10.00 | 12/17/2025 |
4 | TikToks Chinese owner ByteDance inks deal to sell US operations to American investors, including Oracle | 12/18/2025 |
5 | TikTok Breakup Goes Live Oracles 14B Power Play Stuns Wall Street | 12/19/2025 |
6 | Unveiling 3 Undervalued Asian Small Caps With Insider Buying | 12/22/2025 |
7 | Madrigal Pharmaceuticals versus Metagenomi Head-To-Head Comparison | 12/31/2025 |
8 | Undervalued Global Small Caps With Insider Buying In January 2026 | 01/20/2026 |
9 | TikTok deal timeline From proposed ban in 2020 to ByteDance JV for US unit sale in 2026 Heres all you need to know | 01/23/2026 |
10 | MGX Resources materials activity within All Ordinaries market framework | 01/27/2026 |
| Begin Period Cash Flow | 145.9 M | |
| Total Cashflows From Investing Activities | -88.2 M |
Metagenomi | Build AI portfolio with Metagenomi Stock |
Metagenomi Common Relative Risk vs. Return Landscape
If you would invest 244.00 in Metagenomi Common Stock on October 30, 2025 and sell it today you would lose (78.00) from holding Metagenomi Common Stock or give up 31.97% of portfolio value over 90 days. Metagenomi Common Stock is generating negative expected returns assuming volatility of 4.3201% on return distribution over 90 days investment horizon. In other words, 38% of stocks are less volatile than Metagenomi, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Metagenomi Common Target Price Odds to finish over Current Price
The tendency of Metagenomi Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.63 | 90 days | 1.63 | about 75.36 |
Based on a normal probability distribution, the odds of Metagenomi Common to move above the current price in 90 days from now is about 75.36 (This Metagenomi Common Stock probability density function shows the probability of Metagenomi Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.92 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Metagenomi Common will likely underperform. Additionally Metagenomi Common Stock has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Metagenomi Common Price Density |
| Price |
Predictive Modules for Metagenomi Common
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Metagenomi Common Stock. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Metagenomi Common Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Metagenomi Common is not an exception. The market had few large corrections towards the Metagenomi Common's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Metagenomi Common Stock, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Metagenomi Common within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.88 | |
β | Beta against Dow Jones | 1.92 | |
σ | Overall volatility | 0.35 | |
Ir | Information ratio | -0.18 |
Metagenomi Common Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Metagenomi Common for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Metagenomi Common Stock can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Metagenomi Common generated a negative expected return over the last 90 days | |
| Metagenomi Common may become a speculative penny stock | |
| Metagenomi Common has high historical volatility and very poor performance | |
| Metagenomi Common has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 52.3 M. Reported Net Loss for the year was (78.06 M) with loss before taxes, overhead, and interest of (65.18 M). | |
| Metagenomi Common generates negative cash flow from operations | |
| About 29.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from kalkinemedia.com: MGX Resources materials activity within All Ordinaries market framework |
Metagenomi Common Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Metagenomi Stock often depends not only on the future outlook of the current and potential Metagenomi Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Metagenomi Common's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 37.4 M | |
| Cash And Short Term Investments | 248.3 M |
Metagenomi Common Fundamentals Growth
Metagenomi Stock prices reflect investors' perceptions of the future prospects and financial health of Metagenomi Common, and Metagenomi Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Metagenomi Stock performance.
| Return On Equity | -0.41 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (2.87) % | ||||
| Operating Margin | (2.64) % | ||||
| Current Valuation | (79 M) | ||||
| Shares Outstanding | 37.55 M | ||||
| Price To Book | 0.36 X | ||||
| Price To Sales | 2.03 X | ||||
| Revenue | 52.3 M | ||||
| Gross Profit | (65.18 M) | ||||
| EBITDA | (83.49 M) | ||||
| Net Income | (78.06 M) | ||||
| Total Debt | 45.78 M | ||||
| Book Value Per Share | 4.75 X | ||||
| Cash Flow From Operations | (109.07 M) | ||||
| Earnings Per Share | (2.39) X | ||||
| Market Capitalization | 62.7 M | ||||
| Total Asset | 324.6 M | ||||
| Retained Earnings | (223 M) | ||||
| Working Capital | 220.65 M | ||||
About Metagenomi Common Performance
Evaluating Metagenomi Common's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Metagenomi Common has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Metagenomi Common has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.29) | |
| Return On Capital Employed | (0.36) | (0.37) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.38) | (0.36) |
Things to note about Metagenomi Common Stock performance evaluation
Checking the ongoing alerts about Metagenomi Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Metagenomi Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Metagenomi Common generated a negative expected return over the last 90 days | |
| Metagenomi Common may become a speculative penny stock | |
| Metagenomi Common has high historical volatility and very poor performance | |
| Metagenomi Common has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 52.3 M. Reported Net Loss for the year was (78.06 M) with loss before taxes, overhead, and interest of (65.18 M). | |
| Metagenomi Common generates negative cash flow from operations | |
| About 29.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from kalkinemedia.com: MGX Resources materials activity within All Ordinaries market framework |
- Analyzing Metagenomi Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Metagenomi Common's stock is overvalued or undervalued compared to its peers.
- Examining Metagenomi Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Metagenomi Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Metagenomi Common's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Metagenomi Common's stock. These opinions can provide insight into Metagenomi Common's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Metagenomi Stock Analysis
When running Metagenomi Common's price analysis, check to measure Metagenomi Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metagenomi Common is operating at the current time. Most of Metagenomi Common's value examination focuses on studying past and present price action to predict the probability of Metagenomi Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metagenomi Common's price. Additionally, you may evaluate how the addition of Metagenomi Common to your portfolios can decrease your overall portfolio volatility.